Zepto has begun pilot testing two new services to diversify its quick commerce (qcom) portfolio and enter high-value categories. The company is currently trialling Super Mall, a vertical focused on premium, high-ticket products, and Zepto Diagnostics, an in-app service that enhances its pharma category. These pilots are available only in select cities and to a limited customer base as Zepto evaluates their long-term potential.
What Zepto Wants to Achieve With Super Mall
Through the Super Mall initiative, Zepto aims to tap into higher-margin product categories amid intensifying competition. The company wants to attract new users while strengthening retention among existing customers. This new vertical features a wide range of non-grocery items, including electronics, home decor, and fashion.
Moreover, Zepto is using Super Mall to push larger cart sizes. For example, the platform currently offers Rs 50 off on orders above Rs 1,099, Rs 150 off on purchases exceeding Rs 2,299, and Rs 200 off on orders above Rs 2,899. Similarly, Swiggy has introduced its Maxxsaver feature, which unlocks lower prices on orders above Rs 399, underscoring the growing focus on value-driven buying.
How Zepto Diagnostics Strengthens Its Pharma Category
Zepto is also reinforcing its healthcare offerings through Zepto Diagnostics, a service integrated within its Pharmacy vertical. The company has partnered with Orange Health Labs to provide quick, at-home diagnostic testing. Users can book blood tests with sample collection within 60 minutes and receive reports in just six hours.
As reported by Business Standard, the available tests include full-body health checkups, complete blood count (CBC), thyroid function test (TFT), and several others. With this move, Zepto aims to enhance customer convenience and increase the relevance of its pharma services.